Indegene, a digital-first life sciences commercialisation company, has announced a new centre in Hyderabad to strengthen its global delivery operations and better address growing business needs. 

As the pharma industry faces increasing pressure to innovate and adapt, this new centre will play a key role in helping companies accelerate their transformation. This move aligns with Indegene’s purpose: to enable healthcare organisations to be future-ready by combining deep medical expertise with fit-for-purpose technology.

India is rapidly emerging as a critical hub for global pharma companies, fueled by its vast pool of skilled medical and technology talent. These companies are increasingly seeking a partner with core domain expertise and life sciences-contextualised technology to help them scale their operations in a non-linear, technology-led way.

With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. This vast global footprint underscores Indegene’s ability to scale and meet the evolving needs of the world’s leading pharma organizations across markets.